These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16941141)

  • 1. Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients.
    Sebag J; Ansari RR; Suh KI
    Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):576-80. PubMed ID: 16941141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology of pharmacologic vitreolysis.
    Sebag J
    Trans Am Ophthalmol Soc; 2005; 103():473-94. PubMed ID: 17057814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes.
    Sakuma T; Tanaka M; Mizota A; Inoue J; Pakola S
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3295-9. PubMed ID: 16123432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microplasmin: ex vivo characterization of its activity in porcine vitreous.
    de Smet MD; Valmaggia C; Zarranz-Ventura J; Willekens B
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):814-9. PubMed ID: 18806295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential vitreous dye diffusion following microplasmin or plasmin pre-treatment.
    Gad Elkareem AM; Willikens B; Stassen JM; de Smet MD
    Curr Eye Res; 2010 Mar; 35(3):235-41. PubMed ID: 20373883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel vitreous modulators for pharmacologic vitreolysis in the treatment of diabetic retinopathy.
    Costa Ede P; Rodrigues EB; Farah ME; Sebag J; Meyer CH
    Curr Pharm Biotechnol; 2011 Mar; 12(3):410-22. PubMed ID: 20939794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels.
    Quiram PA; Leverenz VR; Baker RM; Dang L; Giblin FJ; Trese MT
    Retina; 2007 Oct; 27(8):1090-6. PubMed ID: 18040251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic vitreodynamics and molecular flux.
    Goldenberg DT; Trese MT
    Dev Ophthalmol; 2009; 44():31-36. PubMed ID: 19494650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior vitreous detachment induced by microplasmin.
    Gandorfer A; Rohleder M; Sethi C; Eckle D; Welge-Lüssen U; Kampik A; Luthert P; Charteris D
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):641-7. PubMed ID: 14744909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental evaluation of microplasmin - an alternative to vital dyes.
    Gandorfer A
    Dev Ophthalmol; 2008; 42():153-159. PubMed ID: 18535388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic vitreolysis with ocriplasmin: rationale for use and therapeutic potential in vitreo-retinal disorders.
    Khoshnevis M; Sebag J
    BioDrugs; 2015 Apr; 29(2):103-12. PubMed ID: 25812991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a stabilized form of microplasmin for the induction of posterior vitreous detachment.
    Gad Elkareem AM; Willekens B; Vanhove M; Noppen B; Stassen JM; de Smet MD
    Curr Eye Res; 2010 Oct; 35(10):909-15. PubMed ID: 20858112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microplasmin-assisted vitrectomy.
    Gandorfer A
    Dev Ophthalmol; 2009; 44():26-30. PubMed ID: 19494649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative imaging of enzymatic vitreolysis-induced fiber remodeling.
    Filas BA; Shah NS; Zhang Q; Shui YB; Lake SP; Beebe DC
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8626-37. PubMed ID: 25468895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic vitreolysis in diabetic retinopathy.
    El-Asrar AM; Al-Mezain HS
    Curr Pharm Biotechnol; 2011 Mar; 12(3):406-9. PubMed ID: 20939804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocriplasmin for pharmacologic vitreolysis.
    Kuppermann BD
    Retina; 2012 Sep; 32 Suppl 2():S225-8; discussion S228-31. PubMed ID: 22929326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic vitreolysis.
    Rhéaume MA; Vavvas D
    Semin Ophthalmol; 2010; 25(5-6):295-302. PubMed ID: 21091015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of plasmin on the vitreolysis in rabbit eyes.
    Kim NJ; Yu HG; Yu YS; Chung H
    Korean J Ophthalmol; 2004 Jun; 18(1):35-40. PubMed ID: 15255235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial.
    de Smet MD; Gandorfer A; Stalmans P; Veckeneer M; Feron E; Pakola S; Kampik A
    Ophthalmology; 2009 Jul; 116(7):1349-55, 1355.e1-2. PubMed ID: 19447497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic vitreolysis: rationale, potential indications, and promising agents.
    Gandorfer A
    Retina; 2012 Sep; 32 Suppl 2():S221-4. PubMed ID: 22929325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.